Preclinical in vivo Neurotoxicity Studies of Drug Candidates
Neurotoxic effects are one of the common reasons for discontinuation of preclinical and/or clinical studies. Preclinical evaluation of neurotoxic effects is complicated due to a wide range of manifestations and degrees of severity. Current experimental approaches to neurotoxicity assessment are cumb...
Saved in:
Main Authors: | N. V. Eremina, L. G. Kolik, R. U. Ostrovskaya, A. D. Durnev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
2020-09-01
|
Series: | Регуляторные исследования и экспертиза лекарственных средств |
Subjects: | |
Online Access: | https://www.vedomostincesmp.ru/jour/article/view/312 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmaceutical Toxicology is the Most Important Component of Preclinical Studies
by: A. D. Durnev
Published: (2023-03-01) -
Preclinical Safety Assessment of Antineoplastic Agents Based on Live Non-Pathogenic Enteroviruses
by: K. V. Sivak, et al.
Published: (2024-12-01) -
Subchronic toxicity of a drug based on D-cyphenothrin, pyriproxyfen and piperonyl butoxide
by: M. V. Arisov, et al.
Published: (2024-12-01) -
Summary of Clinical Laboratory Studies Performed During Preclinical Safety Evaluation of Medicinal Products (Part II: Biochemical and Pathomorphological Studies)
by: A. V. Sorokina, et al.
Published: (2019-12-01) -
Methods of creation of bladder cancer models and their application in preclinical studies (literature review)
by: I. A. Kamaeva, et al.
Published: (2022-05-01)